Hosted on MSN

90% of Phase 2 Sold Fast Thanks to CoinMarketCap Listing, Secure Your Stake in Ruvi AI (RUVI) Before It Hits Solana (SOL) Level Success

The crypto market has witnessed countless projects promise revolutionary returns, but few deliver on their potential. Solana’s incredible journey from $0.04 to over $260 serves as a reminder that life ...
Nasdaq

Olema Pharmaceuticals Selects 90 mg Palazestrant Dose for Phase 3 OPERA-01 and OPERA-02 Trials

Olema Pharmaceuticals has announced that it has selected a 90 mg dosage of palazestrant for the second part of its Phase 3 OPERA-01 monotherapy trial and also for the OPERA-02 combination trial with ...
Nasdaq

Relmada Therapeutics Reports Promising Phase 2 Data for NDV-01 in Non-Muscle Invasive Bladder Cancer with 90% of Patients Achieving Disease-Free Status

100% (n=7) of evaluable patients (1 CIS, 6 Ta/T1) achieved disease free status. One of these patients was re-treated at 3 months. “I am impressed by these promising NDV-01 data reported at AUA2025.
Hosted on MSN

NISAR enters critical 90-day phase

The historic NISAR mission, a landmark collaboration between NASA and ISRO, has entered its crucial 90-day commissioning phase, during which scientists will carry out rigorous checks, calibrations and ...